Skip to content
Catalyst

methylene blueFinding

Methylene blue decreases intensive care unit length of stay

lowersLimited evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“The patients in the MB group (n = 84) have a lower intensive care unit stay duration in days (9 ± 8 days) vs. (16 ± 6.9) in the control group (n = 116).”
Quoted verbatim from The mystery of methylene blue and its role in managing post-cardiac surgery vasoplegic shock.
This finding among the 23 findings on its endpoint

methylene blue

Intensive care unit length of stay

lowers

Who
Adults with norepinephrine-refractory vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass; 84 given methylene blue within 24 h postoperatively versus 116 not given it, all on norepinephrine; retrospective single-centre cohort, MB group significantly younger
Dose studied
2 mg/kg intravenous bolus followed by 0.5 mg/kg/h infusion for 12 h

Limited evidencePMID 39903510 · 2025

02 · The study

Study
cohort
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limitedthis finding
  • very limited
  • insufficient

03 · The paper

Annals of medicine
What else it reported2 findings · 1 compound · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZBH5K3E193HK4ZQSJRYEVA